论文部分内容阅读
目的评估溃疡性结肠炎采取奥沙拉秦联合微生态制剂治疗的临床效果。方法 78例溃疡性结肠炎患者,按随机数字表法分为对照组和观察组,各39例。对照组患者单用奥沙拉秦治疗,观察组在对照组基础上联合微生态制剂治疗。对比两组临床治疗效果及不良反应发生情况。结果观察组治疗总有效率明显高于对照组,差异有统计学意义(P<0.05)。两组不良反应发生率比较差异无统计学意义(P>0.05)。结论采取奥沙拉秦联合微生态制剂治疗溃疡性结肠炎效果显著,安全性高,能够降低不良反应发生率,值得推广应用。
Objective To evaluate the clinical efficacy of olsalazine combined with probiotics in the treatment of ulcerative colitis. Methods A total of 78 patients with ulcerative colitis were divided into control group and observation group according to random number table method, with 39 cases in each. Patients in the control group were treated with olsalazine alone, and the observation group was treated with probiotics on the basis of the control group. Compare the two groups of clinical treatment and adverse reactions. Results The total effective rate of observation group was significantly higher than that of control group, the difference was statistically significant (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion The combination of olsalazine and probiotics in the treatment of ulcerative colitis has obvious effect, high safety and can reduce the incidence of adverse reactions, which is worth popularizing and applying.